Skip to Main Content

Paper Details

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles.
Nature Communications
23
2021
HIV-1, NM1TFV, NM2TFV, NTAF, Sprague Dawley rats, TFV, TFV-DP, TFV-diphosphate, human immunodeficiency virus type, human immunodeficiency virus type one (HIV-1), nucleoside, nucleoside reverse transcriptase, tenofovir, tenofovir alafenamide
Author NameAffiliation
Aditya N BadeUniversity of Nebraska Medical Center
Nagsen GautamDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center
JoEllyn McMillanUniversity of Nebraska Medical Center
Howard E GendelmanUniversity of Nebraska Medical Center
Howard E GendelmanDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center
Benson EdagwaUniversity of Nebraska Medical Center
  • 1 - 6

Datasets

Release 1.2